Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs Duloxetine in Severe Depression
NCT00384436Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Oct 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in major depressive disorder (MDD) (3 arms), sponsored by Forest Laboratories. Primary endpoint: Time to premature discontinuation. Started Oct 2006; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00384436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384436.